Alina Ciobanu, MD
Internal Medicine · Commack, NYNPI 1356349633
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 84 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Johnson & Johnson at 26.5% of the total. Reporting peaked in 2023 at $432 and has fallen 71.9% since, to $121 in 2025.
Across 84 payments — averaging $21.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$487
- AbbVie$315
- Pfizer$298
- Merck$264
- E.r. Squibb & Sons, L.L.C.$194
- Boston Scientific$149
- plus $131 from 5 others
What the payments were for
- Food & beverage$1,838100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 23 | $487 |
| AbbVie | 15 | $315 |
| Pfizer | 13 | $298 |
| Merck | 15 | $264 |
| E.r. Squibb & Sons, L.L.C. | 11 | $194 |
| Boston Scientific | 1 | $149 |
| Novartis | 2 | $46 |
| Braintree Laboratories, Inc. | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $26 |
| Mylan Specialty L.p. | 1 | $17 |
| Smith+Nephew | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- APOLLO ESG System$149
- XARELTO$125
How this compares
$1,838 in reported general payments places this provider in the 80th percentile of 9,771 internal medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Commack
- Jonathan LownCommack$338K
- Jahan AghalarCommack$271K
- David DoveEast Hampton$12.3M
- Bruce BergerBrooklyn$3.4M
- Nicholas RobinsonBuffalo$2.9M
- Stephen SaletanNew York$2.6M
- Ziad AliNew York$2M
- Scott BeegleAlbany$1.9M
- Anthony MartinezBuffalo$1.6M
- Javier MoralesGreenvale$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.